Nuwellis, Inc. (NUWE): Nasdaq/NYSE listing notice — Nuwellis gets 180-day extension to May 29, 2023 to regain Nasdaq $1 bid price compliance

Nuwellis, Inc.

Received 180-day extension from Nasdaq to May 29, 2023 to regain minimum $1.00 bid price compliance.
Initial 180-day compliance period expired Nov 28, 2022; extension granted Nov 29, 2022.
Can regain compliance if bid price closes at $1.00 or more for 10 consecutive business days before May 29, 2023.
No immediate effect on listing; shares continue trading on Nasdaq Capital Market under ticker NUWE.
Company may consider a reverse stock split to meet the requirement; failure could lead to delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Nuwellis, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

November 29, 2022 the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 29, 2023, to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company will continue to monitor the closing bid price of the Common Stock and may, if appropriate, consider implementing available options, including but not limited to, implementing a reverse stock split of its outstanding securities, to regain compliance with the Minimum Bid Price Requirement. If the Company does not regain compliance

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Nuwellis, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-22-043607

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.